Yasir Qazi, MD

Clinical Associate Professor of Medicine (Part-Time)

Image of Yasir Qazi, MD
Is this your profile? Click to edit


After serving as an assistant professor of medicine at Erie County Medical Center at the State University of New York in Buffalo, Dr. Qazi came to Southern California to head the Kidney-Pancreas Transplant Program at Keck School of Medicine at USC. Dr. Qazi has received nearly $2 million in research grants and has several other studies recently submitted for approval.

While in Buffalo, Dr. Qazi was invited to lecture on pancreas transplantation at a number of area medical centers and continues to author numerous peer reviewed articles and abstracts for medical journals. Educated in India, Dr. Qazi was consistently one of the academic leaders among his medical school classmates and he continues to demonstrate his talents and devotion to medicine as an educator, researcher and practitioner.


  • SUNY, Buffalo, New York: Austin-Flint’s Best Outgoing Resident Award, 2000
  • Daemen College for Physician Assistants: Physician Appreciation Award, 1999


  • Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management Transplant Proc. 2021 Dec; 53(10):2866-2872. . View in PubMed
  • Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney Transplantation Ann Transplant. 2021 Jul 02; 26:e932249. . View in PubMed
  • Transplant administration-A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers Clin Transplant. 2021 06; 35(6):e14305. . View in PubMed
  • Liver Transplantation in Patients with Sickle Cell Disease in the United States J Surg Res. 2020 11; 255:23-32. . View in PubMed
  • High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury Am J Transplant. 2020 09; 20(9):2491-2498. . View in PubMed
  • Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study Am J Transplant. 2019 11; 19(11):3018-3034. . View in PubMed
  • Delayed graft function in kidney transplantation Curr Opin Organ Transplant. 2019 02; 24(1):82-86. . View in PubMed
  • Marginal kidney transplantation: the road less traveled Curr Opin Organ Transplant. 2019 02; 24(1):92-96. . View in PubMed
  • Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation J Am Soc Nephrol. 2018 07; 29(7):1979-1991. . View in PubMed
  • Kidney outcomes in patients with liver cirrhosis and chronic kidney disease receiving an orthotopic liver transplant alone Clin Transplant. 2017 Sep; 31(9). . View in PubMed
  • Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus Am J Transplant. 2017 Sep; 17(9):2363-2371. . View in PubMed
  • Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data Am J Transplant. 2017 May; 17(5):1358-1369. . View in PubMed
  • Duplex Doppler sonography: is there clinical relevance to elevated renal vein velocity in kidney transplants? Clin Imaging. 2016 Nov – Dec; 40(6):1237-1245.. View in PubMed
  • Kidney transplantation in the Hispanic population Clin Transplant. 2016 Feb; 30(2):118-23. . View in PubMed
  • Evaluation of a telenovela designed to improve knowledge and behavioral intentions among Hispanic patients with end-stage renal disease in Southern California Ethn Health. 2016; 21(1):58-70. . View in PubMed
  • Bortezomib in kidney transplantation Curr Opin Organ Transplant. 2015 Dec; 20(6):652-6. . View in PubMed
  • Editorial Curr Opin Organ Transplant. 2015 Dec; 20(6):629. . View in PubMed
  • In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study Eye (Lond). 2015 Aug; 29(8):1099-110. . View in PubMed
  • Strategies for the management of adverse events associated with mTOR inhibitors Transplant Rev (Orlando). 2014 Jul; 28(3):126-33. . View in PubMed
  • Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1a and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid Transpl Immunol. 2013 Dec; 29(1-4):155-61. . View in PubMed
  • Posttransplant malignancies in solid organ adult recipients: an analysis of the US. National Transplant Database. Transplantation. 2012 Nov 27; 94(10):990-8. . View in PubMed
  • Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients Transpl Infect Dis. 2012 Jun; 14(3):305-10. . View in PubMed
  • A rapid and efficient method BK polyomavirus genotyping by high-resolution melting analysis J Med Virol. 2011 Dec; 83(12):2128-34. . View in PubMed
  • The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity Ther Drug Monit. 2011 Feb; 33(1):45-9. . View in PubMed
  • Development of a real-time quantitative PCR assay for detection of a stable genomic region of BK virus Virol J. 2010 Oct 29; 7:295. . View in PubMed
  • Foxp3 staining in BK virus allograft nephropathy and comparison with acute cellular rejection Transplant Proc. 2009 Dec; 41(10):4188-92. . View in PubMed
  • Current Opinion in Organ TransplantationEditorial comment. Curr Opin Organ Transplant. 2009 Aug; 14(4):364. . View in PubMed
  • Incentivizing living organ donation Curr Opin Organ Transplant. 2009 Apr; 14(2):201-5. . View in PubMed
  • Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection Transpl Immunol. 2009 Jan; 20(3):113-7. . View in PubMed
  • Costimulation targeting therapies in organ transplantation Curr Opin Organ Transplant. 2008 Dec; 13(6):622-6. . View in PubMed
  • Living related donor nephrectomy in transfusion refusing donors Transpl Int. 2007 Jun; 20(6):490-6. . View in PubMed
  • The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function Clin Transplant. 2006 May-Jun; 20(3):313-7. . View in PubMed
  • Donor calculi induced acute renal failure Ren Fail. 2003 Mar; 25(2):315-22. . View in PubMed

Similar People